www.i-canadianpharmacy.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Dutasteride - Avodart
Generic Avodart
Generic Avodart is used for treating symptoms of benign prostatic hyperplasia (BPH) or enlargement of the prostate gland. It also helps to reduce the risk of urinary blockage and the need for prostate surgery.
$0.83
Buy now!
Choose Your language:
- Testimonials
-
I already received my parcel, I had a problem as the courier wanted to deliver to my home as they claim they cannot place the order into my postbox. This was my preferred option.
Read more »
There is not someone at home always, so we had to get the parcel to my office. No problem with that.
I did have an enquiry into the 4 extra pills, and this was delivered within a few days via airmail to my post box.
I would suggest you attend to this part of your process as the extra cost is unnecessary. Include everything into one parcel.
All in all, good service. - Jan
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Dutasteride May Decrease Risk of BPH Clinical Progression - Renal and Urology News
- Dutasteride May Decrease Risk of BPH Clinical ProgressionRenal and Urology NewsATLANTA—Men with enlarged prostates may be able to decrease the likelihood of clinical progression of their condition by taking dutasteride, according to study findings presented at the American Urological Association 2012 annual meeting
- Cholesterol-lowering drugs may slow prostate growth - EurekAlert (press release)
- Daily MailCholesterol-lowering drugs may slow prostate growthEurekAlert (press release)Muller and colleagues used data gathered for an unrelated, large trial originally testing whether a drug called dutasteride could help reduce the risk of prostate cancer
- Dutasteride May Slow Prostate Cancer Progression - OncLive
- OncLiveDutasteride May Slow Prostate Cancer ProgressionOncLiveDutasteride, a 5α-reductase inhibitor approved for the treatment of benign prostatic hyperplasia, may postpone disease progression in men with low-risk prostate cancer who have opted for an active surveillance strategy, as well as the need to start
- Coronary Artery Disease May Boost Risk of Prostate Cancer - OncLive
- OncLiveCoronary Artery Disease May Boost Risk of Prostate CancerOncLiveThe 4-year, phase III REDUCE study evaluated the 5α-reductase inhibitor dutasteride, 0
- New Therapy Is Essential for Men with Prostate Enlargement As Medications Have ... - Seattle Post Intelligencer
- New Therapy Is Essential for Men with Prostate Enlargement As Medications Have
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
